Amgen SWOT Analysis, USP & Competitors

Amgen

Parent Company

Amgen

Category

Biopharmaceutical Company

Sector

Pharma and Healthcare

Tagline/ Slogan

Pioneering Science Delivers Vital Medicines

USP

One of the leading companies in the world in transforming new ideas and discoveries into medicines for patients with serious illnesses

Amgen STP

Segment

Based on the seriousness of diseases people are suffering from

Target Group

People suffering from serious diseases and diseases with very limited number of treatment options

Positioning

Values based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses

Amgen SWOT Analysis

Strengths

1. Continuous innovation and development of new products

2. World’s largest independent biotechnology firm

3. Pipelines and biosimilars programs continue to make progress

4. High Brand recognition among users

5. Over 17000 people are employed with the organization the world over

6. Acquisition of companies have strengthened its position in the industry

Weaknesses

1. Huge costs incurred for research and development of new products

2.Very limited sales and marketing options

3.Sales of some of the most popular products are falling

Opportunities

1.There are still many life threatening diseases with no cures which can be developed

2.Expansion to Asian and African markets

3.With new innovations in technology, more opportunity for growth

Threats

1.Sales of products affected by third party payers including government and US legislation affecting pharmaceutical pricing

2.Research, processing, testing and selling subject to extensive regulation by domestic and foreign government regulatory authorities

3.Protection provided by patents is limited and can be challenged by competitors

Amgen Competition

Competitors

1.Biogen Idec

2.Celgene

3.Gilead Sciences